TwinStrand Biosciences Says USPTO Confirms Patentability of Core Sequencing Patent
The company says all 23 claims of the exclusively licensed ’631 patent remain intact after an unappealed USPTO decision.
The company says all 23 claims of the exclusively licensed ’631 patent remain intact after an unappealed USPTO decision.